Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,074 public trials 1,189 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

Registry for Advanced Endoscopy

NCT05187312

Conditions: Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, +16 more
Locations: Karolinska University Hospital Stockholm, Sweden

View Trial Details

Recruiting

Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer

NCT06363006

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH) Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer

NCT05080556

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
Locations: University College London Hospitals London, United Kingdom

View Trial Details

Recruiting

Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

NCT03981497

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
Locations: IRCCS Ospedale San Raffaele Milan, Italy

View Trial Details

Recruiting

Liver Embolization Approaches for Tumor Management

NCT05714124

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +32 more
Locations: IRCCS Ospedale San Raffaele Milan, Italy

View Trial Details

Recruiting

European Active Surveillance of Renal Cell Carcinoma Study (EASE RCC Study)

NCT06336187

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Ospedale Maggiore della Carità Novara, Italy

View Trial Details

Recruiting

Immunotherapy for Hepatocellular Carcinoma

NCT06241326

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Jiangsu Province Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC

NCT05652920

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

Hunan Cancer Hospital Changsha, Hunan, China

The first hospital of Jilin University Changchun, Jilin, China

West China Hospital Chengdu, Sichuan, China

View Trial Details

Recruiting

A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma

NCT06326502

Conditions: Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +11 more
Locations: Seoul National University Hospital Seoul, South Korea

Severance Hospital Seoul, South Korea

View Trial Details

Recruiting

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

NCT06265025

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +47 more
Locations: National Cancer Center Goyang-si, Gyeonggi-do, South Korea

Korea University Anam Hospital Seoul, South Korea

Hanyang University Seoul Hospital Seoul, South Korea

Severance Hospital, Yonsei University Health System Seoul, South Korea

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions